Medindia

X

Specialty Active Pharmaceutical Ingredient (API) Market: Popularity of Peptide-based Drugs Growing

Wednesday, August 3, 2016 Drug News J E 4
Advertisement

VALLEY COTTAGE, New York, August 3, 2016 /PRNewswire/ --

The global specialty active pharmaceutical ingredients (API) market is anticipated to record a year-over-year growth rate of 7.9% and reach a market value of US$ 119,513.1 Mn in 2016. Small molecules will continue to account for the leading market revenue share by product type, accounting for over two-thirds share in 2016.

Staggering increase in the manufacturing of HPAPI (high potency API) will continue to influence the adoption of API positively. Popularity of peptide-based drugs and the patent expiry of blockbuster branded drugs in the near future is also expected to boost the growth of the market. However, complex manufacturing guidelines and stringent regulatory processes will continue to pose challenges to widespread adoption.

Request a Sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1719

By product type, growth of the small molecules segment will be positively impacted by increasing outsourcing of active pharmaceutical ingredients manufacturing from European to Asian countries. In addition, rising preference for HPAPI to treat cancer will play a crucial role in the growth of small molecule segment of the global specialty API market.

Based on the consumption pattern, the outsourced segment will continue to dominate market revenues, accounting for nearly 65% share in 2016. New pharmaceutical companies are increasingly entering the market with authorized and approved HPAPI, but lack of manufacturing facility infrastructure is providing an impetus to the outsourcing trend in terms of manufacturing. This factor is currently more pronounced in U.S.-based companies. Furthermore, the tendency of established pharmaceutical companies to curtail the operational and financial load of HPAPI manufacturing is anticipated to play a key role in elevating the outsourcing segment, boosting the growth of SMEs in the market.

Free Analysis Global Specialty Active Pharmaceutical Ingredients Market by Product: http://www.futuremarketinsights.com/reports/specialty-active-pharmaceutical-ingredients-market

FMI's report has segmented the global specialty active pharmaceutical ingredient market on the basis of region into North America, Europe, and Rest of the World (ROW). The ROW is the leading region in terms of global revenue share, closely followed by Europe and North America. European API manufacturers are competing on the basis of high quality standards, advanced manufacturing installations, and high purity of intermediates (API), whereas ROW CMOs are focusing on bulk API manufacturing.

The key players in the small molecule active pharmaceutical ingredients segment include Johnson Matthey, Almac, and Siegfried Holding AG, which follow advanced manufacturing technology, premium promotion strategies, and provide a range of development and diagnostic services.

Notable companies in the peptide API segment are PolyPeptide Laboratories, Corden Pharma International GmbH (International Chemical Investors Group), Pepscan Holding, Provence Technologies Group, BCN Peptides S.A., and Senn Chemicals AG. They are characterized on the basis of expertise in development and manufacturing, strong client base, and activity in a wide range of industries.

Speak with Analyst for any report related queries: http://www.futuremarketinsights.com/askus/rep-gb-1719

Major HPAPI players in the market are Ash Stevens, Inc., Orion Corporation, Farmhispania Group, S.L., Olon S.p.A., and AmbioPharm, Inc., based on widespread market presence, government approvals, and strong distribution channels.

Long-term Outlook: The global specialty API market is expected to witness a CAGR of 8.8% during the forecast period 2016-2024. ROW will continue to be the leading region in terms of revenues during the forecast period.   

FMI Latest Insights: 

  • Silent Scan Technology Market: http://www.futuremarketinsights.com/reports/silent-scan-technology-market
  • Anti-ageing Products, Services and Devices Market: http://www.futuremarketinsights.com/reports/anti-aging-market
  • Veterinary Vaccines Market: http://www.futuremarketinsights.com/reports/veterinary-vaccines-market

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: sales@futuremarketinsights.com

Website: http://www.futuremarketinsights.com

Press Release: http://www.futuremarketinsights.com/press-release

SOURCE Future Market Insights

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Physicians Endoscopy Adds Pain Management Specialt...
S
Dental Benefits Can Save American Businesses' Mone...